DK116056B - Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge. - Google Patents
Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge.Info
- Publication number
- DK116056B DK116056B DK228263AA DK228263A DK116056B DK 116056 B DK116056 B DK 116056B DK 228263A A DK228263A A DK 228263AA DK 228263 A DK228263 A DK 228263A DK 116056 B DK116056 B DK 116056B
- Authority
- DK
- Denmark
- Prior art keywords
- gona
- dien
- homo
- analogues
- ones
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Transmission Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19497262A | 1962-05-15 | 1962-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK116056B true DK116056B (da) | 1969-12-08 |
Family
ID=22719572
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK228263AA DK116056B (da) | 1962-05-15 | 1963-05-14 | Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge. |
| DK228063AA DK114340B (da) | 1962-05-15 | 1963-05-14 | Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK228063AA DK114340B (da) | 1962-05-15 | 1963-05-14 | Fremgangsmåde til fremstilling af terapeutisk virksomme gona-4,9-dien-3-oner eller de tilsvarende D-homoforbindelser. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3502699A (xx) |
| JP (1) | JPS4812737B1 (xx) |
| AT (2) | AT272532B (xx) |
| BR (1) | BR6349095D0 (xx) |
| CH (1) | CH494213A (xx) |
| DE (3) | DE1468642B1 (xx) |
| DK (2) | DK116056B (xx) |
| ES (2) | ES288360A1 (xx) |
| FI (1) | FI41741B (xx) |
| FR (1) | FR3896M (xx) |
| IT (1) | IT1061776B (xx) |
| NO (2) | NO124598B (xx) |
| SE (5) | SE323668B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3723533A (en) * | 1968-02-27 | 1973-03-27 | American Cyanamid Co | Substituted naphthalenone and naphthalenedione compounds |
| JPS5320840Y2 (xx) * | 1973-11-21 | 1978-06-01 | ||
| DE2718872A1 (de) * | 1976-06-14 | 1977-12-22 | Jenapharm Veb | Verfahren zur herstellung von neuen gona-4,9(10)-dienen |
| FR2618783B1 (fr) * | 1987-07-30 | 1991-02-01 | Roussel Uclaf | Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant |
| WO2015057894A1 (en) * | 2013-10-15 | 2015-04-23 | Massachusetts Institute Of Technology | Methods for treating polycystic kidney disease and polycystic liver disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3069421A (en) * | 1961-04-12 | 1962-12-18 | Roussel Uclaf | Process for the preparation of delta5(10)-estrene-17beta-ol-3-one and intermediates |
-
1962
- 1962-05-15 US US194972A patent/US3502699A/en not_active Expired - Lifetime
-
1963
- 1963-05-09 DE DE19631468642 patent/DE1468642B1/de active Pending
- 1963-05-09 DE DE1618973A patent/DE1618973C3/de not_active Expired
- 1963-05-09 DE DE1793633A patent/DE1793633C3/de not_active Expired
- 1963-05-13 CH CH597463A patent/CH494213A/de not_active IP Right Cessation
- 1963-05-13 BR BR149095/63A patent/BR6349095D0/pt unknown
- 1963-05-13 SE SE5253/63A patent/SE323668B/xx unknown
- 1963-05-13 FI FI0988/63A patent/FI41741B/fi active
- 1963-05-13 NO NO148646A patent/NO124598B/no unknown
- 1963-05-13 SE SE5254/63A patent/SE323669B/xx unknown
- 1963-05-14 DK DK228263AA patent/DK116056B/da unknown
- 1963-05-14 DK DK228063AA patent/DK114340B/da unknown
- 1963-05-14 ES ES288360A patent/ES288360A1/es not_active Expired
- 1963-05-14 AT AT390463A patent/AT272532B/de active
- 1963-05-14 NO NO148662A patent/NO124597B/no unknown
- 1963-05-14 AT AT00125/68A patent/AT283609B/de not_active IP Right Cessation
- 1963-05-14 IT IT10052/63A patent/IT1061776B/it active
- 1963-05-14 ES ES288359A patent/ES288359A1/es not_active Expired
- 1963-05-15 JP JP38024255A patent/JPS4812737B1/ja active Pending
- 1963-08-11 FR FR944790A patent/FR3896M/fr not_active Expired
-
1967
- 1967-01-09 SE SE00289/67A patent/SE330164B/xx unknown
- 1967-01-09 SE SE00290/67A patent/SE330165B/xx unknown
- 1967-01-09 SE SE00288/67A patent/SE330166B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR3896M (xx) | 1966-02-07 |
| DE1793633C3 (de) | 1973-10-04 |
| DE1618973A1 (de) | 1971-12-30 |
| US3502699A (en) | 1970-03-24 |
| DE1793633A1 (de) | 1971-12-30 |
| NO124598B (xx) | 1972-05-08 |
| SE323669B (xx) | 1970-05-11 |
| BR6349095D0 (pt) | 1973-08-02 |
| AT283609B (de) | 1970-08-10 |
| DK114340B (da) | 1969-06-23 |
| CH494213A (de) | 1970-07-31 |
| DE1793633B2 (de) | 1973-03-08 |
| SE323668B (xx) | 1970-05-11 |
| IT1061776B (it) | 1983-04-30 |
| FI41741B (xx) | 1969-10-31 |
| AT272532B (de) | 1969-07-10 |
| ES288359A1 (es) | 1963-12-01 |
| JPS4812737B1 (xx) | 1973-04-23 |
| NO124597B (xx) | 1972-05-08 |
| DE1618973B2 (de) | 1973-10-31 |
| SE330164B (xx) | 1970-11-09 |
| SE330166B (xx) | 1970-11-09 |
| SE330165B (xx) | 1970-11-09 |
| ES288360A1 (es) | 1963-12-01 |
| DE1618973C3 (de) | 1974-06-06 |
| DE1468642B1 (de) | 1971-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK107029C (da) | Fremgangsmåde til fremstilling af substituerede 2-arylamino-1,3-diazacycloalkener eller syreadditionssalte deraf. | |
| DK115403B (da) | Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner. | |
| DK112949B (da) | Fremgangsmåde til fremstilling af O-mycaminosyl-tylonolid eller dihydro-O-mycaminosyl-tylonolid. | |
| DK107024C (da) | Fremgangsmåde til fremstilling af 4-amino-6,7-dialkoxykinoliner eller syreadditionssalte deraf. | |
| DK109037C (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf. | |
| DK106185C (da) | Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner. | |
| DK116056B (da) | Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge. | |
| DK108227C (da) | Fremgangsmåde til fremstilling af 3-carbonhydridoxy-17α-halogenethinyl-19-nor-3,5-androstadien-17β-oler. | |
| DK124753B (da) | Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler. | |
| DK107876C (da) | Fremgangsmåde til fremstilling af phenylethanolaminer eller salte heraf. | |
| DK104303C (da) | Fremgangsmåde til fremstilling af 3α-hydroxy-11-oxo-21,21-bis-(hydroxymethyl)-5β-pregnan eller estere deraf. | |
| DK103188C (da) | Fremgangsmåde til fremstilling af endometylen-2,3-dimetylhexahydropyridazin eller kvaternære ammoniumforbindelser deraf. | |
| DK105462C (da) | Fremgangsmåde til fremstilling af O-acetyl-3,5-dimethylbenzheparid eller alkalimetalsalte heraf. | |
| DK111525B (da) | Fremgangsmåde til fremstilling af monoalkylamino-propyliden-dibenzo-[b,e]-oksepin- eller -tiepinderivater eller deres hydrohalogenider. | |
| DK109871C (da) | Fremgangsmåde til fremstilling af 2-aminometyl-3,4-dihydro-2H-pyraner eller derivater deraf. | |
| DK112381B (da) | Fremgangsmåde til fremstilling af 16-fluormethylen-17α-hydroxy-20-keto-steroider af pregnan-, 19-nor-pregnan- eller iso-pregnanrækken eller 17α-estere deraf. | |
| DK106091C (da) | Fremgangsmåde til fremstilling af 17α-alkyl-17β-hydroxy-2-azaandrostan-3-oner eller 17α-alkyl-17β-hydroxy-3-aza-A-homoandrostan-4-oner. | |
| DK105983C (da) | Fremgangsmåde til fremstilling af 2-alkoxy-5-aryl-3H-1,4-benzodiazepin-4-oxider. | |
| DK103239C (da) | Fremgangsmåde til fremstilling af 2,3-dicyan-1,4-dithia-anthrahydroquinon eller 2,3-dicyan-1,4-dithia-anthraquinon. | |
| DK114902B (da) | Fremgangsmåde til fremstilling af O,S-disubstituerede thiol-thiaminderivater. | |
| DK113576B (da) | Fremgangsmåde til fremstilling af benzensulfonyl-semicarbazider eller salte deraf. | |
| DK102182C (da) | Fremgangsmåde til fremstilling af 3-sulfanilamido-4,5-dialkyl-isoxazoler eller salte deraf. | |
| DK98301C (da) | Fremgangsmåde til fremstilling af 4-sulfonamido-5,6-dialkoxy-pyrimidiner eller salte deraf. | |
| DK101003C (da) | Fremgangsmåde til fremstilling af 4-sulfanilamido-2-alkyl-5,6-dialkoxy-pyrimidiner eller salte deraf. | |
| DK100948C (da) | Fremgangsmåde til fremstilling af 4-sulfanilamido-2-alkyl-5,6-dialkoxypyrimidiner eller salte deraf. |